Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Name: Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)
Published: 2020
License: Public Domain

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

head-and-neck-cancer nivolumab squamous-cell-carcinoma

recurrent/metastatic head and neck squamous cell carcinoma, head and neck cancer, squamous cell carcinoma, nivolumab, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Related documents